Vimarsana
Biggest News Aggregation in the World

Page 10 - Sci Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sci Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sci Capital Today - Breaking & Trending Today

Allarity Therapeutics Lists on US Nasdaq Stock Market - Vimarsana News

Allarity Therapeutics Lists on US Nasdaq Stock Market

The firm, previously based in Denmark, has closed its recapitalization share exchange and listed over 8 million shares of common stock on the Nasdaq.

MEI Pharma Announces Pricing of Public Offering of Common Stock - Vimarsana News

MEI Pharma Announces Pricing of Public Offering of Common Stock

02.12.2021 - MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced today that it has priced the underwritten public offering of 17,500,000 shares of its common stock at $2.60 per share for ... Seite 1

MEI Pharma Announces Pricing of Public Offering of Common Stock - Vimarsana News

MEI Pharma Announces Pricing of Public Offering of Common Stock

SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced today that it has priced the underwritten public offering of 17,500,000 shares of its common stock at $2.60 per share for total gross proceeds (before underwriting...

Shares in Ventyx Bio jump 31 percent in first day of trading - The San Diego Union-Tribune - Vimarsana News

Shares in Ventyx Bio jump 31 percent in first day of trading - The San Diego Union-Tribune

Ventyx Biosciences joins cadre of San Diego life sciences companies to go public this year. It is pursuing drugs for psoriasis, Crohn’s disease and other ailments.

Ventyx Biosciences Announces Pricing of Upsized Initial - Vimarsana News

Ventyx Biosciences Announces Pricing of Upsized Initial

ENCINITAS, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing...